Chemed Corp. (CHE)

NYSE Health Care Health Care Services S&P MidCap 400
$528.05
-5.72 (-1.07%)
Close of Nov 06, 2026 · end-of-day data
Source: Chemed Corp.'s 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$1.58B$1.67B$1.20B$1.28B$1.33B$1.26B$1.20B$1.32B$1.53B$2.53B
Cost of revenue$1.12B$1.15B$1.23B$1.32B$1.38B$1.37B$1.37B$1.47B$1.58B$1.71B
Gross profit$461.45M$516.19M-$30.08M-$39.94M-$43.53M-$108.21M-$168.31M-$150.54M-$45.96M$823.18M
Selling, general & admin$243.57M$276.65M$271.21M$305.71M$330.22M$366.73M$358.73M$395.12M$424.36M$417.19M
Operating income$178.75M$113.03M$243.63M$257.38M$389.68M$343.04M$343.50M$340.57M$366.49M$338.25M
Interest expense$3.71M$4.27M$4.99M$4.54M$2.35M$1.87M$4.58M$3.11M$1.78M$1.75M
Pre-tax income$177.05M$116.92M$239.60M$261.61M$395.99M$350.31M$329.68M$350.37M$399.46M$355.78M
Income tax$68.31M$18.74M$34.06M$41.69M$76.52M$81.76M$80.06M$77.86M$97.47M$90.54M
Net income$108.74M$98.18M$205.54M$219.92M$319.47M$268.55M$249.62M$272.51M$302.00M$265.24M
EBITDA$213.39M$148.66M$282.50M$302.58M$446.26M$402.09M$402.67M$401.43M$429.54M$403.09M
EPS (basic)$6.64$6.11$12.80$13.77$20.02$17.14$16.72$18.11$20.10$18.42
EPS (diluted)$6.48$5.86$12.23$13.31$19.48$16.85$16.53$17.93$19.89$18.34
Diluted shares16.79M16.74M16.80M16.53M16.40M15.94M15.10M15.20M15.19M14.46M
Gross margin29.3%31.0%-2.5%-3.1%-3.3%-8.6%-14.0%-11.4%-3.0%32.5%
Operating margin11.3%6.8%20.3%20.1%29.2%27.2%28.6%25.9%23.9%13.4%
Net margin6.9%5.9%17.2%17.2%23.9%21.3%20.8%20.7%19.7%10.5%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$15.31M$11.12M$4.83M$6.16M$162.68M$32.90M$74.13M$263.96M$178.35M$74.52M
Receivables$132.02M$113.65M$119.50M$143.83M$126.85M$137.22M$139.41M$181.51M$171.16M$182.57M
Inventory$5.75M$5.33M$5.71M$7.46M$7.09M$10.11M$10.27M$12.00M$8.19M$7.54M
Total current assets$169.90M$176.05M$159.84M$190.67M$329.40M$230.29M$272.61M$500.84M$394.75M$302.62M
Goodwill$472.37M$476.89M$510.57M$577.37M$578.59M$578.59M$581.29M$585.02M$666.74M$667.00M
Total assets$880.06M$920.03M$975.53M$1.27B$1.43B$1.34B$1.44B$1.67B$1.67B$1.54B
Total current liabilities$171.83M$193.52M$191.67M$262.22M$299.11M$302.40M$297.20M$312.05M$285.69M$287.13M
Short-term debt$8.75M$10.00M————$5.00M———
Long-term debt$100.00M$91.20M$89.20M$90.00M—$185.00M$92.50M———
Total debt$108.75M$101.20M$89.20M$90.00M—$185.00M$97.50M———
Total liabilities$355.96M$379.67M$384.19M$541.71M$533.71M$719.45M$643.30M$560.22M$549.58M$558.78M
Shareholders' equity$524.10M$540.35M$591.33M$726.61M$901.20M$623.27M$798.72M$1.11B$1.12B$979.40M

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$135.39M$162.50M$287.14M$301.25M$489.29M$308.60M$309.89M$330.30M$417.50M$388.27M
Capital expenditures$39.77M$64.30M$52.87M$53.02M$58.83M$58.67M$57.33M$56.85M$49.53M$62.80M
Free cash flow$95.62M$98.19M$234.27M$248.23M$430.46M$249.92M$252.56M$273.44M$367.97M$325.48M
Investing cash flow-$39.86M-$67.61M-$105.22M-$190.76M-$61.56M-$57.76M-$59.40M-$60.64M-$143.91M-$59.34M
Financing cash flow-$94.95M-$99.08M-$188.20M-$109.16M-$271.21M-$380.62M-$209.25M-$79.83M-$359.19M-$432.77M
Dividends paid$16.44M$17.37M$18.66M$19.79M$21.08M$22.02M$22.02M$23.50M$27.09M$31.70M
Share buybacks$102.31M$94.64M$158.88M$92.63M$175.59M$576.04M$114.52M$67.70M$361.39M$431.50M
Stock-based compensation$13.77M$16.26M$19.23M$21.34M$26.80M$31.42M$33.61M$40.79M$52.11M$38.68M
Depreciation & amortization$34.64M$35.62M$38.86M$45.20M$56.58M$59.05M$59.17M$60.87M$63.05M$64.84M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.